Winnow Wealth’s ResMed RMD Stock Holding History

Winnow Wealth’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-197	Closed	-$47.5K	–	461
2025 Q4	$47.5K	Hold	197	–	–	0.04%	165
2025 Q3	$54K	Buy	+197	New	+$53.8K	0.04%	161
2025 Q2	–	Sell	-201	Closed	-$44.8K	–	571
2025 Q1	$44.8K	Buy	201 +1	+0.5%	+$233	0.04%	158
2024 Q4	$45.5K	Buy	+200	New	+$48.2K	0.05%	145

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Winnow Wealth's RMD Position: Q1 2026 in Review

Winnow Wealth sold out of ResMed (RMD) in Q1 2026, closing a stake of 197 shares — an estimated $47.5K sold.

Winnow Wealth first reported a position in RMD in Q4 2024 and held it in 4 quarters. The position peaked at $54K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Winnow Wealth reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
Winnow Wealth sold 197 ResMed shares in Q1 2026, an estimated $47.5K.
Winnow Wealth first reported a position in ResMed in Q4 2024 and held it in 4 quarters.
Winnow Wealth's ResMed position peaked at $54K in Q3 2025.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Winnow Wealth's 13F filing for Q1 2026, filed 19 May 2026.